Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 105-107

  Uzawa, Akiyuki ^a   Mori, Masahiro ^a   Iwai, Yuhta ^a   Kobayashi, Makoto ^a   Hayakawa, Sei ^a   Kawaguchi, Naoki ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Anti acetylcholine receptor antibody; Anti aquaporin 4 antibody; Myasthenia gravis; Neuromyelitis optica; Thymectomy

Indexed keywords

AQUAPORIN 4; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; MYASTHENIA GRAVIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; OPTIC NEURITIS; PLASMAPHERESIS; PRIORITY JOURNAL; QUADRIPLEGIA; SENSORY DYSFUNCTION; SPINAL CORD LESION; THYMUS HYPERPLASIA; VISUAL IMPAIRMENT;

AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; BLINDNESS; CENTRAL NERVOUS SYSTEM; CONTINENTAL POPULATION GROUPS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; NEUROMYELITIS OPTICA; OPTIC NERVE; PERIPHERAL NERVOUS SYSTEM; QUADRIPLEGIA; RECEPTORS, CHOLINERGIC; SPINAL CORD; THYMECTOMY;

EID: 70350618309     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.040     Document Type: Article

References (19)

1. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
2. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130 (2007) 1235-1243
3. Jarius S., Aboul-Enein F., Waters P., Kuenz B., Hauser A., Berger T., et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131 (2008) 3072-3080
4. Vincent A., Palace J., and Hilton-Jones D. Myasthenia gravis. Lancet 357 (2001) 2122-2128
5. Isbister C.M., Mackenzie P.J., Anderson D., Wade N.K., and Oger J. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 9 (2003) 550-553
6. Antoine J.C., Camdessanché J.P., Absi L., Lassablière F., and Féasson L. Devic disease and thymoma with anti-central nervous system and antithymus antibodies. Neurology 62 (2004) 978-980
7. Furukawa Y., Yoshikawa H., Yachie A., and Yamada M. Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur J Neurol 13 (2006) 655-658
8. Kister I., Gulati S., Boz C., Bergamaschi R., Piccolo G., Oger J., et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 63 (2006) 851-856
9. Gotkine M., Fellig Y., and Abramsky O. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 67 (2006) 881-883
10. Nakamura M., Nakashima I., Sato S., Miyazawa I., Fujihara K., and Itoyama Y. Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands. Mult Scler 13 (2007) 332-335
11. Ikeda K., Araki Y., and Iwasaki Y. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 68 (2007) 1326
12. Bichuetti D.B., Barros T.M., Oliveira E.M., Annes M., and Gabbai A.A. Demyelinating disease in patients with myasthenia gravis. Arq Neuropsiquiatr 66 (2008) 5-7
13. Kay C.S., Scola R.H., Lorenzoni P.J., Jarius S., Arruda W.O., and Werneck L.C. NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 275 (2008) 148-150
14. Hayakawa S., Mori M., Okuta A., Kamegawa A., Fujiyoshi Y., Yoshiyama Y., et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 196 (2008) 181-187
15. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
16. McKeon A., Lennon V.A., Jacob A., Matiello M., Lucchinetti C.F., Kale N., et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39 (2009) 87-90
17. Gerli R., Paganelli R., Cossarizza A., Muscat C., Piccolo G., Barbieri D., et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 103 (1999) 865-872
18. Alves-Leon S.V., Pimentel M.L., Sant'Anna G., Malfetano F.R., Estrada C.D., and Quirico-Santos T. Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica. Arq Neuropsiquiatr 66 (2008) 678-684
19. Dau P.C. Plasmapheresis therapy in myasthenia gravis. Muscle Nerve 3 (1980) 468-482